Andrea DiFabio
Förmögenhet: 457 554 $ per 2026-07-31
Förmögenhet: 457 554 $ per 2026-07-31
Andrea DiFabio is Secretary & Chief Legal Officer at Xenon Pharmaceuticals, Inc. since 2022.
Former roles include Secretary, Chief Legal & Administrative Officer at Repertoire Immune Medicines, Inc. from 2020 to 2022; Secretary, Chief Legal Officer & Executive VP at Bioverativ, Inc. from 2016 to 2018; Chief Research & Business Development Counsel at Biogen, Inc. from 2006 to 2017; Chief Legal Officer at Codiak BioSciences, Inc.; Vice President & Deputy General Counsel at PAREXEL International Corp.; and Director-Northeast Chapter at the Association of Corporate Counsel.
Education includes undergraduate studies at Boston University and graduate studies at Northeastern University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-07 | 7 301 ( 0,01 % ) | 457 554 $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| XENON PHARMACEUTICALS INC. | Generell Rådgivare | 2022-11-07 |
| Företag | Position | Slut |
|---|---|---|
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Administrativ Direktör | 2022-10-01 |
| BIOVERATIV INC | Generell Rådgivare | 2018-06-01 |
| BIOGEN INC. | Företagsledare/Principal | 2017-02-01 |
| CODIAK BIOSCIENCES | Generell Rådgivare | - |
Association of Corporate Counsel
Association of Corporate Counsel Miscellaneous Commercial ServicesCommercial Services Operates as a business professionals association | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 9 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
PAREXEL International Corp.
PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xenon Pharmaceuticals, Inc.
Xenon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of therapeutics for neurological & psychiatric disorders | Health Technology |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Association of Corporate Counsel
Association of Corporate Counsel Miscellaneous Commercial ServicesCommercial Services Operates as a business professionals association | Commercial Services |
Codiak BioSciences, Inc.
Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops exosome based therapeutics | Health Technology |
Bioverativ, Inc.
Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders | Health Technology |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån